• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Mirati CEO Steps Down After Going Toe-to-Toe with Amgen in KRAS

cafead

Administrator
Staff member
  • cafead   Aug 09, 2023 at 12:12: PM
via Mirati Therapeutics on Tuesday announced that CEO David Meek has resigned from his post, with founder and president Charles Baum taking the company’s reins as it searches for a permanent replacement.

article source